Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check4 days agoChange DetectedRelated topics section now includes 'Multiple myeloma' and a link to 'MedlinePlus Genetics'. This addition places the study in the disease context and improves navigation to genetics-related information.SummaryDifference0.1%

- Check11 days agoChange DetectedA new site revision tag 'Revision: v3.5.4' was added, indicating an updated build. Several topic labels and the previous revision tag 'Revision: v3.5.3' were removed (e.g., 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics'), reflecting a cleanup of page topics and metadata.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page removes the explicit disease tag and related topics references, altering how the condition is identified and where related resources are shown.SummaryDifference0.1%

- Check25 days agoChange DetectedThe study page now includes new related topics: Multiple myeloma and MedlinePlus Genetics, updating its categorization and linkage to disease and genetics resources.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now shows a different site revision identifier (v3.5.3 instead of v3.5.2) and the associated “related topics” section content appears to have been adjusted. This does not change the trial’s study details or scientific/participant-relevant information.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now includes the 'Multiple myeloma' tag and a MedlinePlus Genetics related topics link, and the revision version was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.